Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults

Go back to Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults
Pfizer Inc. (NYSE: PFE) Delayed: 27.63 -0.03 (0.11%)
Previous Close $27.66    52 Week High $37.39 
Open $27.65    52 Week Low $28.25 
Day High $27.79    P/E 16.75 
Day Low $27.53    EPS $1.65 
Volume 4,152,425